Bio Pharma Dive
APRIL 6, 2021
The influential drug cost watchdog recommended a discount of between 37% and 54% to the $419,500 list price the companies charge for Abecma, a multiple myeloma cell therapy cleared by the FDA in March.
pharmaphorum
APRIL 6, 2021
From #MeToo to Black Lives Matter, as a society we have been discussing the relationship between representation and equality more than ever over the last few years. . But while progress is being made in so many areas, people with disabilities are still struggling to find a voice above the accepted narrative, says Ross Lannon, the 27-year-old blogger and multi-media content creator behind A Life on Wheels.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
APRIL 6, 2021
Some seven months after acquiring the rest of Akcea Therapeutics, Ionis is laying off most of its subsidiary's staff and turning to Sobi to sell its drugs.
XTalks
APRIL 6, 2021
Most grocery shoppers won’t soon forget the perplexing moment last spring when shelves were suddenly bare. Where flour, pasta and other shelf-stable goods once sat in abundance quickly emptied to nothing but price tags. The same went for meat and dairy. It was a shocking, yet humbling, sight for most. The news of farmers dumping milk, letting crops rot and euthanizing chickens only added to the disarray.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
APRIL 6, 2021
An experimental medicine from Scholar Rock could complement drugs from Biogen, Novartis and Roche, though its benefit needs to be proven in further study.
XTalks
APRIL 6, 2021
The US Food and Drug Administration (FDA) has granted approval to the world’s first non-surgical pulmonary valve to treat severe pulmonary valve regurgitation, a condition often resulting from congenital heart disease. The device, developed by world-leading medical technology company Medtronic , is indicated for both pediatric and adult patients who have severe pulmonary valve regurgitation.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Druggist
APRIL 6, 2021
Lacri-lube has been out of stock for months. Still, after all this time, some patients get repeat prescriptions issued with Laci-Lube on it. Patients who have Lacri-Lube eye ointment on their ‘repeats’ should contact their surgery and ask to remove it and replace it with Lacri-lube alternative eye ointments. I will list in this post the best Lacri-Lube alternative eye ointments and gels.
pharmaphorum
APRIL 6, 2021
People in the UK will start receiving doses of Moderna’s COVID-19 vaccine in around two weeks’ time, according to vaccines minister Nadhim Zahawi. The roll-out of the third coronavirus shot will come as the UK exits its second lockdown round, and in time to offset an anticipated dip in supply of the Oxford University/AstraZeneca AZD1222 vaccine in the coming weeks.
BioPharma Reporter
APRIL 6, 2021
When BioNTech calls 2020 a transformational year, itâs something of an understatement: with the company partnering with Pfizer to bring the first mRNA COVID-19 vaccine to market. So whatâs next? BioNTech pledges to accelerate and expand its innovation pipeline with projects such as new mRNA vaccines and a boosted oncology pipeline to âbuild a 21st century global immunotherapy powerhouseâ.
Pharma Times
APRIL 6, 2021
The 2021 Communications Awards have opened their doors for entry, inviting the very best in pharma communications to come forward and claim first prize.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
APRIL 6, 2021
Reparative hydrogel mimics the composition and mechanics of the brain Credit: University of Georgia At a cost of $38 billion a year, an estimated 5.3 million people are living with a permanent disability related to traumatic brain injury in the United States today, according to the Centers for Disease Control and Prevention. The physical, mental […].
BioSpace
APRIL 6, 2021
It takes money to develop new, innovative treatments and this morning, multiple companies have announced significant fundraises. A summary of each financing round is below.
Scienmag
APRIL 6, 2021
SwSP-100 now available through the $6 billion Rapid Spacecraft Acquisition IV contract Credit: SwRI SAN ANTONIO — April 6, 2021 — NASA has selected Southwest Research Institute’s 100 kg-class small satellite (SmallSat) platform to be listed in the Rapid Spacecraft Development Office (RSDO) IV catalog used by the U.S. government to rapidly contract for flight-proven […].
BioSpace
APRIL 6, 2021
The landscape may begin to become clearer as real-time research continues to emerge about the long-term effects of COVID-19 infection.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
APRIL 6, 2021
Credit: Couple 3 Films April 6, 2021 – NEW YORK – With major funding from the Alfred P. Sloan Foundation, the film IN SILICO is bringing the opportunities and challenges of “big data” neuroscience to virtual screens across North America on April 30th. The independent documentary chronicles an audacious 10-year quest to simulate the entire […].
BioSpace
APRIL 6, 2021
The $3.1 million NCATS grant will help the company test SPI-1005 in two trials, both OK’d by the U.S. Food and Drug Administration (FDA) last August.
Scienmag
APRIL 6, 2021
Credit: Manchester University Press WHO needs feminism? The short answer to this question is everyone. This and the issues involved were discussed when a panel of inspirational women came together to celebrate the launch of a new book titled, The Futures of Feminism written by the University of Huddersfield’s Professor Emerita of Politics, Valerie Bryson. […].
Intouch Solutions
APRIL 6, 2021
In the face of relentless trauma, how can pharma more effectively convey important information while also building, improving, and sustaining relationships with HCPs as they care for patients? An Intouch MD weighs in. The post Marketing to HCPs as We Emerge From the COVID-19 Pandemic appeared first on Intouch Solutions.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
pharmaphorum
APRIL 6, 2021
UK digital health company Oxehealth has claimed FDA approval for software that can be used to remotely measure vital signs like heart and breathing rates from a camera feed. . Oxehealth Vital Signs – which has been approved as a class IIa medical device in Europe since 2018 – operates as part of the company’s Oxevision platform, which consists of an optical sensor installed in a patient’s room and provides continuous remote monitoring.
Scienmag
APRIL 6, 2021
Provides 2.24x higher performance than previous system Credit: JAIST and Dell Technologies Japan Advanced Institute of Science and Technology (“JAIST”; Nomi City, Ishikawa Prefecture ; President: Minoru Terano) and Dell Technologies Co., Ltd. (Kawasaki City, Kanagawa Prefecture ; President: Toshihiko Otsuka ) announced JAIST adopted Dell EMC PE R6525 SCS, a supercomputer system based on […].
pharmaphorum
APRIL 6, 2021
A new organisation dedicated to increasing the use of digital health in the NHS in Wales has come into being, 18 months after the move was first unveiled by the Welsh government. . Digital Health and Care Wales (DHCW) – which has emerged from the now defunct NHS Wales Informatics Service (NWIS) – will be tasked with providing the national technology and data services needed by patients and clinicians.
BioSpace
APRIL 6, 2021
Workplace conflict is bound to happen throughout your career. Learn how to take advantage of moments of discord to identify opportunities for growth, learning, and collaboration while also steering clear of highly toxic people who thrive on conflict.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
APRIL 6, 2021
Researchers identify gene that helps plants sense heat Credit: Meng Chen/UCR By 2050 global warming could reduce crop yields by one-third. UC Riverside researchers have identified a gene that could put the genie back in the bottle. Warmer temperatures signal to plants that summer is coming. Anticipating less water, they flower early then lack the […].
Pharma Times
APRIL 6, 2021
Everyone in England, including those without symptoms, will be able to take a free rapid coronavirus test twice a week
BioSpace
APRIL 6, 2021
Artios Pharma Limited has entered into a global research collaboration with Novartis for the purpose of discovering and validating next-generation DDR targets and enhancing Novartis’ radioligand therapies.
Scienmag
APRIL 6, 2021
Scientists discovered microRNA-29 is an important cellular switch controlling late-stage brain development, a foundational discovery that will help researchers explore new therapeutic approaches for neurodevelopmental conditions. Credit: Deshmukh Lab, UNC School of Medicine CHAPEL HILL, NC – A team led by scientists at the UNC School of Medicine identified a molecule called microRNA-29 as a […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioSpace
APRIL 6, 2021
At this time Vaccitech hasn’t priced its offering, although the report suggests they might sometime this month.
Scienmag
APRIL 6, 2021
A Berkeley Lab-led team is digging into the bizarre bacteria-produced nanomachines that could fast-track microbiome science Credit: Antara Mutalik Imagine there are arrows that are lethal when fired on your enemies yet harmless if they fall on your friends. It’s easy to see how these would be an amazing advantage in warfare, if they were […].
Pharma Times
APRIL 6, 2021
Funding backed for reversal of gastrointestinal bleeds but not for intracranial haemorrhage
Scienmag
APRIL 6, 2021
Research provides insight into mechanistic factors that alter hepatic drug disposition during pregnancy Credit: BioIVT BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be hosting a webinar on April 8 at 11 a.m. ET entitled “Effect of Pregnancy-related Hormones on CYP Induction: Implications for […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
296 
Let's personalize your content